Advanced search
Publication Cover
Expert Review of Hematology Volume 12, 2019 - Issue 2
Submit an article Journal homepage
368
Views
13
CrossRef citations to date
0
Altmetric
Original Research

A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment

Richard F. PollockHealth Economics, Covalence Research Ltd, London, UKView further author information
&
Gorden MudumaInternational Market Access, Pharmacosmos A/S, Holbæk, DenmarkCorrespondence[email protected]
View further author information
Pages 129-136 | Received 09 Nov 2018, Accepted 23 Jan 2019, Published online: 19 Feb 2019

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shanlian Hu, Limin Liu, Richard F. Pollock, Johannes Pöhlmann, Depei Wu & Yabing Zhang. (2022) Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose. Journal of Medical Economics 25:1, pages 561-570.
Read now
Richard F. Pollock & Gorden Muduma. (2020) A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom. Journal of Medical Economics 23:7, pages 751-759.
Read now

Articles from other publishers (11)

Lu Yun, Zhu YuMei, Vallish BN, Qingu Tang & Chang Feng. (2023) The Efficacy, Safety, and Economic Outcomes of Using Ferric Derisomaltose for the Management of Iron Deficiency in China: A Rapid Health Technology Assessment. Cureus.
Crossref
Ho Jung Jung, Min Wook Kang, Jong Hwa Lee, Joon Kyu Lee & Joong Il Kim. (2023) The Association of Intravenous Iron Administered the Day before Total Knee Arthroplasty with Postoperative Anemia and Functional Recovery. Medicina 59:7, pages 1212.
Crossref
Rebecca Harding, Ernest Moya, Ricardo Ataíde, Zinenani Truwah, Glory Mzembe, Gomezgani Mhango, Ayşe V. Demir, William Stones, Louise Randall, Marc Seal, Katherine Johnson, Stefan Bode, Martin N. Mwangi, Sant-Rayn Pasricha, Sabine Braat & Kamija S. Phiri. (2023) Protocol and statistical analysis plan for a randomized controlled trial of the effect of intravenous iron on anemia in Malawian pregnant women in their third trimester (REVAMP – TT). Gates Open Research 7, pages 117.
Crossref
R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, O. A. Gromova & I. Yu. Torshin. (2022) Pharmacoeconomic analysis of using Monofer in patients with iron deficiency anemia as part of the provision of medical care under the state guarantees program in the health care system of the Russian Federation. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 15:1, pages 73-86.
Crossref
Benedikt Schaefer, Heinz Zoller & Myles Wolf. (2022) Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose. The Journal of Clinical Endocrinology & Metabolism 107:4, pages 1009-1019.
Crossref
Michael Auerbach, Maureen M. Achebe, Lars L. Thomsen & Richard J. Derman. (2022) Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery. Obesity Surgery 32:3, pages 810-818.
Crossref
Tim Aung & Sandy T. Aung. (2021) Iron infusion and newer intravenous iron formulations. Chinese Medical Journal 134:15, pages 1889-1890.
Crossref
CHIMSOM OLEKA & JENNIFER E. DIETRICH. (2020) HMB in the Adolescent: A Review of the Modern Approach to Diagnosis and Management. Clinical Obstetrics & Gynecology 63:3, pages 553-560.
Crossref
Frank Loughnane, Gorden Muduma & Richard F. Pollock. (2020) Development of a Resource Impact Model for Clinics Treating Pre-Operative Iron Deficiency Anemia in Ireland. Advances in Therapy 37:3, pages 1218-1232.
Crossref
Nicole Ebner & Stephan von Haehling. (2019) Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure?. Cardiac Failure Review 5:3, pages 173-175.
Crossref
Richard F. Pollock & Gorden Muduma. (2019) Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark. Advances in Therapy 36:8, pages 1821-1825.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.